| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ca0841c52dc980c3f201762d410f79b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D265-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665d4401885832ac77c4e93d85a2c79c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb19b1c6976fa9645ffa77fce14de02c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b01e3cd8870c86f77dcf564d3cf9362 |
| publicationDate |
2018-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108779073-A |
| titleOfInvention |
Compositions and methods for treating cancer |
| abstract |
A method of treating cancer in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a PP2A activator and a protein kinase inhibitor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114984221-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113616795-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112816453-A |
| priorityDate |
2015-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |